Help | RSS Feed



EyePoint Pharmaceuticals, Inc. (NASD:EYPT) Seasonal Chart

Seasonal Chart Analysis

Analysis of the EyePoint Pharmaceuticals, Inc. (NASD:EYPT) seasonal charts above shows that a Buy Date of February 16 and a Sell Date of May 30 has resulted in a geometric average return of 21.54% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 45.6% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

EyePoint Pharmaceuticals Inc is a US-based specialty pharmaceutical company which is engaged in developing sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company has developed three sustained-release products for the treatment of back-of-the-eye diseases. The lead product candidate is Durasert which is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye for three years from a single injection. The company’s development program is focused primarily on utilizing two core technology platforms to deliver drugs and biologics to treat chronic diseases.

To download EYPT seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore